3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
11
Myelodysplastic Syndromes
4
Sarcoma, Myeloid
2
Leukemia, Monocytic, Acute
2
Leukemia, Hairy Cell
2
Leukemia, Biphenotypic, Acute
2
Blast Crisis
2
Targeted Therapy
1
Recurrence
1
Myeloproliferative Disorders
1
Myasthenia Gravis
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Interventions
Biopsy
9
Specimen Handling
8
Magnetic Resonance Spectroscopy
6
duvelisib
5
Cyclophosphamide
5
ruxolitinib
4
Vincristine
4
10-propargyl-10-deazaaminopterin
4
pembrolizumab
3
X-Rays
3
Prednisone
3
Etoposide
3
Doxorubicin
3
tazemetostat
2
sodium-iodide symporter
2
cemiplimab
2
belinostat
2
Photons
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Immunoglobulin G
2
Disulfides
2
Cytarabine
2
Bortezomib
2
Azacitidine
2
venetoclax
1
talimogene laherparepvec
1
romidepsin
1
prednylidene
1
pegylated granulocyte colony-stimulating factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell
×
Cladribine
×
90 days
×
Clear all
No trials found.